372 views
Genetic Design and Manufacturing Corporation

GDMC secures $28.1m capital from Series A funding 

Celadon Partners led the founding round.

SG-based biotech firm Genetic Design and Manufacturing Corporation (GDMC) secured $28.1m (US$21m) from a Series A funding round led by Celadon Partners.

WI Harper Group, SEEDS Capital, and NSG Ventures also participated in the funding round.

GDMC said it plans to use the funds to promote novel technology and process efficiency improvements to drive greater manufacturing cost reductions for partners aiming to advance medicines through clinical trials and towards commercialisation.

The biotech firm is currently constructing a 155,000 sq ft pre-clinical, clinical, and commercial facility supporting Cell, Gene, and Nucleic Acid Therapies (CGNT).

GDMC has already signed their first clients and is taking reservations for the clinical and commercial facilities expected to open in a staggered format from 2024 to 2027.

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.